A Case Report of Atypical Hemolytic Uremic Syndrome in a Two-Month-Old Infant With a Negative Reported Genetic Profile and Five-Year Follow-Up on Eculizumab

Atypical hemolytic uremic syndrome (aHUS) is a rare but life-threatening pediatric disease caused by uncontrolled activation of the alternative complement pathway related to genetic mutations and carries a worse prognosis. In the last decade, a monoclonal antibody against complement C5, eculizumab,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Siddharth, Sweis, Laith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Medical Education
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489445/
https://www.ncbi.nlm.nih.gov/pubmed/32944483
http://dx.doi.org/10.7759/cureus.10392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489445/
https://www.ncbi.nlm.nih.gov/pubmed/32944483
http://dx.doi.org/10.7759/cureus.10392

Ejemplares similares